These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2244814)

  • 41. Radioimmunological imaging of metastatic prostatic cancer with 111indium-labeled monoclonal antibody PAY 276.
    Babaian RJ; Murray JL; Lamki LM; Haynie TP; Hersh EM; Rosenblum MG; Glenn HJ; Unger MW; Carlo DJ; von Eschenbach AC
    J Urol; 1987 Mar; 137(3):439-43. PubMed ID: 3820371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radioimmunoscintigraphy of colon cancer with iodine-131-labeled B72.3 monoclonal antibody.
    Carrasquillo JA; Sugarbaker P; Colcher D; Reynolds JC; Esteban J; Bryant G; Keenan AM; Perentesis P; Yokoyama K; Simpson DE
    J Nucl Med; 1988 Jun; 29(6):1022-30. PubMed ID: 3373312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen. Experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials.
    Patt YZ; Podoloff DA; Curley S; Smith R; Badkhamkar VA; Lamki LM; Jessup MM; Hohn DC
    Cancer; 1993 Jun; 71(12 Suppl):4293-7. PubMed ID: 8389662
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymphoscintigraphy of human colorectal carcinoma metastases in athymic mice by use of radioiodinated B72.3 monoclonal antibody.
    Shah SA; Gallagher BM; Sands H
    J Natl Cancer Inst; 1987 Jun; 78(6):1069-77. PubMed ID: 3473248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
    Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peritoneal carcinomatosis: imaging with intraperitoneal injection of I-131-labeled B72.3 monoclonal antibody.
    Carrasquillo JA; Sugarbaker P; Colcher D; Reynolds JC; Esteban J; Bryant G; Perentesis P; Yokoyama K; Rotman M; Schlom J
    Radiology; 1988 Apr; 167(1):35-40. PubMed ID: 3347742
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative dual label study of first and second generation antitumor-associated glycoprotein-72 monoclonal antibodies in colorectal cancer patients.
    Gallinger S; Reilly RM; Kirsh JC; Odze RD; Schmocker BJ; Hay K; Polihronis J; Damani MT; Shpitz B; Stern HS
    Cancer Res; 1993 Jan; 53(2):271-8. PubMed ID: 8417820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gamma probe location of 111indium-labeled B72.3: an extension of immunoscintigraphy.
    Krag DN; Haseman MK; Ford P; Smith L; Taylor MH; Schneider P; Goodnight JE
    J Surg Oncol; 1992 Dec; 51(4):226-30. PubMed ID: 1434652
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [In vivo application of monoclonal antibodies in the management of human carcinomas].
    Ohuchi N; Colcher D; Schlom J
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1109-14. PubMed ID: 3291770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma.
    Willkomm P; Bender H; Bangard M; Decker P; Grünwald F; Biersack HJ
    J Nucl Med; 2000 Oct; 41(10):1657-63. PubMed ID: 11037995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical pharmacology, metabolism, and tissue distribution of 90Y-labeled monoclonal antibody B72.3 after intraperitoneal administration.
    Rosenblum MG; Kavanagh JJ; Burke TW; Wharton JT; Cunningham JE; Shanken LJ; Silva EG; Thompson L; Cheung L; Lamki L
    J Natl Cancer Inst; 1991 Nov; 83(22):1629-36. PubMed ID: 1721093
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contribution of SPECT to imaging of gastrointestinal adenocarcinoma with 111In-labeled anti-CEA monoclonal antibody.
    Kramer EL; Sanger JJ; Walsh C; Kanamuller H; Unger MW; Halverson C
    AJR Am J Roentgenol; 1988 Oct; 151(4):697-703. PubMed ID: 3048063
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Frequent anti-V-region immune response to mouse B72.3 monoclonal antibody.
    Khazaeli MB; Saleh MN; Liu T; Kaladas PM; Gilman SC; LoBuglio AF
    J Clin Immunol; 1992 Mar; 12(2):116-21. PubMed ID: 1373150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunoscintigraphy of colorectal cancer with an antibody to epithelial membrane antigen (EMA).
    Yiu CY; Baker LA; Davidson BR; Ward M; Roberts K; Clarke G; Ward C; Westwood J; Boulos PB; Clark CG
    Dis Colon Rectum; 1990 Feb; 33(2):122-6. PubMed ID: 2404713
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of radioimmunoscintigraphy on the management of colorectal and ovarian cancer patients: a retrospective study.
    Blend MJ; Bhadkamkar VA
    Cancer Invest; 1998; 16(7):431-41. PubMed ID: 9774949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of B72.3 iodine 125-labeled monoclonal antibody in colorectal cancer detection by radioimmunoguided surgery.
    Di Carlo V; Badellino F; Stella M; De Nardi P; Fazio F; Percivale P; Bertoglio S; Schenone F; Benevento A; Carcano G
    Surgery; 1994 Feb; 115(2):190-8. PubMed ID: 8310407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radioimmune localization of occult carcinoma.
    Duda RB; Zimmer AM; Rosen ST; Gilyon KA; Webber D; Spies S; Spies W; Merchant B
    Arch Surg; 1990 Jul; 125(7):866-70. PubMed ID: 2369311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
    Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
    Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
    Johnston WW
    Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phenotypic characterization of lung cancers in fine needle aspiration biopsies using monoclonal antibody B72.3.
    Johnston WW; Szpak CA; Thor A; Schlom J
    Cancer Res; 1986 Dec; 46(12 Pt 1):6462-70. PubMed ID: 3022920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.